Technical issues, regulatory hurdles, societal stagnancy. All three of these pose a threat to the advancement of personalized medicine. But perhaps the greatest issue, according to Xconomy's Luke Timmerman, is a lack of sufficient samples.
...and receive Daily News bulletins.
Already have an account?Login Now.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.